Status:
UNKNOWN
Towards Understanding the Relationship Between Meals and Blood Biomarkers
Lead Sponsor:
Texas A&M University
Collaborating Sponsors:
U.S. National Science Foundation
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to establish the reasonableness of using food-based photo diaries and continuous glucose monitors (CGM) to engage in counterfactual thinking strategies. These strategies m...
Detailed Description
The long-term objective of this project is to create a counterfactual-based lifestyle intervention that curtails the progression of prediabetes to T2DM through management and knowledge of food choices...
Eligibility Criteria
Inclusion
- Ability to walk, sit down and stand up independently
- Family history of type 2 diabetes
- Overweight/obese status (BMI\>= 25)
- Subject is judged to be in satisfactory health based on medical history, physical examination
- Willingness and ability to comply with the protocol
- HbA1C levels are within the pre-diabetic range (5.7-6.4%) or fasting plasma glucose 100-125 mg/dL
- Access to a smartphone device and willing to use WhatsApp to communicate with research personnel
Exclusion
- Subject has planned elective surgery requiring 2 or more days of hospitalization during the entire study
- Planned medical procedures that are documented to interfere with CGM readings, such as:
- Xylose absorption testing (oral sugar testing)
- CT
- MRI
- X-ray
- Diathermy treatment (high-frequency electric current to stimulate heat generation within body tissues)
- Established diagnosis of malignancy
- Presence of acute illness or metabolically unstable chronic illness
- Any other condition according to the PI, nurse, or study coordinator that was found during the screening visit, that would interfere with the study or safety of the patient
- Failure to give informed consent or Investigator's uncertainty about the willingness or ability of the subject to comply with the protocol requirements
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05295706
Start Date
June 1 2022
End Date
December 1 2022
Last Update
May 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Translational Research in Age and Longevity
College Station, Texas, United States, 77845